Adjuvant chemotherapy with mFOLFOXIRI versus mFOLFOX6 in MRD-positive stage II-III colorectal cancer

被引：0
|
作者：
Zhang, Jianwei
Hu, Huabin
Cai, Yue
Xie, Xiaoyu
Wu, Zehua
Ling, Jiayu
Chen, Dianke
Liu, Ping
Kang, Liang
Deng, Yanhong
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China
[4] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3642
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A single-centre experience of adjuvant oxaliplatin based chemotherapy in elderly stage II-III colorectal cancer patients
    Reed, H.
    Wooden, A.
    de Winton, E.
    Gangadhara, S.
    Cox, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S160 - S160
  • [22] A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
    Wolmark, N.
    Yothers, G.
    O'Connell, M. J.
    Sharif, S.
    Atkins, J. N.
    Seay, T. E.
    Feherenbacher, L.
    O'Reilly, S.
    Allegra, C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
    Wolmark, N.
    Yothers, G.
    O'Connell, M. J.
    Sharif, S.
    Atkins, J. N.
    Seay, T. E.
    Feherenbacher, L.
    O'Reilly, S.
    Allegra, C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [24] Adjuvant chemotherapy in stage II colorectal cancer
    Kubicka, Stefan
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (09) : 496 - 497
  • [25] Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial
    Takahashi, Takao
    Ishida, Kazuyuki
    Emi, Yasunori
    Sakamoto, Michiie
    Imura, Johji
    Aishima, Shinichi
    Muro, Kei
    Uetake, Hiroyuki
    Oki, Eiji
    Katayose, Yu
    Yoshida, Kazuhiro
    Unno, Michiaki
    Hyodo, Ichinosuke
    Tomita, Naohiro
    Sugihara, Kenichi
    Maehara, Yoshihiko
    CANCERS, 2022, 14 (18)
  • [26] MFOLFOX6 plus CEDIRANIB VS MFOLFOX6 plus BEVACIZUMAB IN PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER (MCRC): A RANDOMIZED, DOUBLE-BLIND, PHASE II/III STUDY (HORIZON III)
    Schmoll, H.
    Cunningham, D.
    Sobrero, A.
    Karapetis, C.
    Rougier, P.
    Koski, S. L.
    Barker, P.
    Mookerjee, B.
    Robertson, J.
    van Cutsem, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 189 - 189
  • [27] Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer
    Matthews, Benjamin J.
    Qureshi, Muhammad Mustafa
    Fiascone, Stephen J.
    Nitschmann, Caroline C.
    Oladeru, Oluwadamilola T.
    Truong, Minh-Tam
    Hirsch, Ariel E.
    Mak, Kimberley S.
    Dyer, M. A.
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : 27 - 33
  • [28] Glycemic Variability in Patients With Stage II-III Colon Cancer Treated With Surgery and Adjuvant Chemotherapy
    Mandolfo, Natalie Rasmussen
    Berger, Ann M.
    Struwe, Leeza A.
    Shade, Marcia Y.
    Goldner, Whitney
    Klute, Kelsey
    Langenfeld, Sean J.
    Hammer, Marilyn J.
    ONCOLOGY NURSING FORUM, 2022, 49 (06) : 571 - 584
  • [29] A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy
    Kazuhiko Yoshimatsu
    Keiichiro Ishibashi
    Keiji Koda
    Hajime Yokomizo
    Noritaka Oda
    Mitsuru Oshiro
    Hiroyuki Kato
    Masatoshi Oya
    Hideo Nakajima
    Shinji Ooki
    Hiroshi Maekawa
    Toshio Matsunami
    Masahiro Tsubaki
    Takeshi Yamada
    Michiya Kobayashi
    Kohji Tanakaya
    Masaru Yokoyama
    Hideyuki Ishida
    Surgery Today, 2019, 49 : 498 - 506
  • [30] A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy
    Yoshimatsu, Kazuhiko
    Ishibashi, Keiichiro
    Koda, Keiji
    Yokomizo, Hajime
    Oda, Noritaka
    Oshiro, Mitsuru
    Kato, Hiroyuki
    Oya, Masatoshi
    Nakajima, Hideo
    Ooki, Shinji
    Maekawa, Hiroshi
    Matsunami, Toshio
    Tsubaki, Masahiro
    Yamada, Takeshi
    Kobayashi, Michiya
    Tanakaya, Kohji
    Yokoyama, Masaru
    Ishida, Hideyuki
    SURGERY TODAY, 2019, 49 (06) : 498 - 506
12345